NV40:FRA
Cellectar Biosciences Inc
0,25 €
0,00%
(0,00) 1D
24 qer, 8:08:19 p.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investing News Network
·
1 orë më parë
Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia
Investing.com Canada
·
3 orë më parë
Cellectar reports trial data for cancer drug in rare disease By Investing.com
Stock Titan
·
3 orë më parë
Cancer treatment responses lasted a median 16 months in Cellectar's study